U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it approved the ...
The approval follows an independent panel voting 19-0 in support of allowing for the product that reduces or reverses opioid overdoses to be given the OTC stamp. Northwell Health’s Sandeep Kapoor, MD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback